Status:
COMPLETED
Multi-Detector CT Angiography With 3D Reconstruction Versus Digital Subtraction Angiography
Lead Sponsor:
Assiut University
Conditions:
Hepatocellular Carcinoma
Eligibility:
All Genders
Brief Summary
This study aims to investigate the feasibility and accuracy of Multi-Detector CT angiography acquired before Trans-arterial Chemo-embolization (TACE) in detecting Hepato-cellular carcinoma feeding ves...
Detailed Description
Hepatocellular carcinoma (HCC) represents the sixth most common cancer worldwide. Trans-arterial chemoembolization (TACE) is a palliative treatment for patients with HCC who are not candidates for tra...
Eligibility Criteria
Inclusion
- Patients with HCC not suitable for resection, liver transplantation, or percutaneous ablation.
- CHILD class A/B cirrhosis.
- patent main portal vein.
- less than 50% involvement of the liver by the tumor.
- no vascular invasion or extrahepatic spread of the HCC.
- normal renal functions.
- bilirubin level \< 2 mg/dl .
Exclusion
- Pre-TACE Multi-Detector CT raw DICOM images could not be obtained for 3D processing
- patients with only available Pre-TACE MRI images
- Failed TACE due to technical factors
- Non-selective TACE technique
Key Trial Info
Start Date :
May 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2023
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT05304572
Start Date
May 1 2022
End Date
June 1 2023
Last Update
June 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut Universtiy Hospital; Alrajhy Liver institute
Asyut, Egypt, 71515